Centessa (CNTA) Soars to All-Time High on 38% Upside from Eli Lilly Merger

Centessa Pharmaceuticals PLC (NASDAQ:CNTA) is one of the 10 Stocks Dominating Today’s Market Surge.

Centessa soared to a new all-time high on Tuesday, as investors gobbled up shares following news that it is set to be acquired by giant weight loss drugmaker Eli Lilly and Company, for $6.3 billion.

In a statement, Eli Lilly said that it entered into a definitive agreement with Centessa Pharmaceuticals PLC (NASDAQ:CNTA) for the acquisition of its shares at a price of $38, or a 38 percent upside from its closing price of $27.58 prior to the announcement.

In addition, shareholders of Centessa Pharmaceuticals PLC (NASDAQ:CNTA) are set to receive $9 upon the achievement of three milestones, including $2 upon FDA approval of cleminorexton for narcolepsy type 2; $5 upon its FDA approval for the treatment of idiopathic hypersomnia; and $2 for its treatment of any indication prior to January 1, 2030. Payments of the contingent value right are not guaranteed.

The transaction is expected to be completed in the third quarter of the year, subject to closing conditions, including regulatory approvals.

“We are thrilled to take our next step toward a potential combination with Lilly, which shares our vision. By combining Centessa’s team and capabilities with Lilly’s global complementary research, clinical, regulatory, and commercial capabilities, we will seek to accelerate the advancement of our orexin portfolio across a broad range of neuroscience indications for the benefit of patients in need,” Centessa Pharmaceuticals PLC (NASDAQ:CNTA) CEO Mario Alberto Accardi said.

While we acknowledge the risk and potential of CNTA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CNTA and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.